Signal from the log
Arcato Laboratories
United States · Biotech
Laboratoire de Caroline du Nord qui développe ARC-001 Gel, un anesthésique local à libération prolongée contre la douleur après extraction dentaire. Le communiqué annonce des résultats de phase 1 et la clôture d'un tour souscrit, sans montant ni fonds nommé.
Spotted Amount read from the headline
Announced on , logged by the watch of 19 August 2026.
- Operation
- Funding round
- Country
- United States
- Sector
- Biotech
What the log says
Editorial note, in French
Repérée par la collecte. Personne ne l'a encore instruite.
What is missing before publishing
- No fund is publicly named. It is the first condition of the selection bar: without a named investor there is no round to tell.
- No public amount. A missing amount is never estimated or inferred from a filing.
- The stage of the round is not disclosed. A letter is never inferred from an amount or a track record.
Provenance
Source prnewswire
Logged on 19 August 2026
Description Written in French during the watch run. Based on the headline as relayed by the source, without reading the issuer's press release.
Verification The fields shown come from an automatic reading of the source headline. They have not yet been checked against the press release and should not be quoted as verified.
What this status means
Spotted The collection saw this operation and logged it. Nobody has processed it yet, so what is shown is still an automatic reading of the source headline.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.